Develops an enzymatic and microbial recycling platform that depolymerizes bio-based plastics (PLA and PHA) into constituent monomers, then converts those monomers into new polymers or high-value chemicals. The workflow uses enzymatic hydrolysis followed by microbial fermentation and downstream purification to recover material-value feedstocks rather than fuels, supporting circular-economy packaging pathways and lower-carbon material cycles.
This research program develops an enzymatic and microbial recycling platform for bio-based plastics, specifically polylactic acid (PLA) and polyhydroxyalkanoates (PHA), which are increasingly used in sustainable packaging. The process depolymerizes these plastics into their constituent monomers and then ferments those monomers into new polymers or high-value chemicals, creating a circular pathway that diverts bio-based packaging from landfill and reduces reliance on fossil-derived inputs.
The approach addresses two converging market pressures: growing regulatory and consumer demand for genuinely recyclable packaging, and corporate net-zero commitments that require lower-carbon material cycles. The work is intended to validate integration into real packaging operations and demonstrate both environmental and economic viability at scale.
Recycling workflow:
Key features:
The hypothesis has not yet been validated experimentally. Near-term validation requires detailed laboratory studies on enzymatic and microbial depolymerization efficiency, optimization of fermentation yields, and assessment of economic feasibility and environmental sustainability. The current stage is early-stage applied research, with the next milestone being bench-scale experimental validation of the combined enzymatic and fermentation process.
The University of Birmingham is a comprehensive public research university of significant scale in the UK’s second city. For industry, a campus‑adjacent research park provides office and wet‑lab space, including the BioHub biomedical incubator managed by University of Birmingham Enterprise. Clinical collaboration is enabled through Birmingham Health Partners, aligning the university with NHS hospital trusts for translational studies and access to patient pathways. Energy and sustainability ventures tap the Birmingham Energy Innovation Centre and wider facilities at Tyseley Energy Park, creating a proving ground for low‑carbon technologies and scale‑up. Research is backed by competitive UK funding, including UKRI councils, Innovate UK, and NIHR, and a dedicated tech transfer office manages IP, licensing, and spinouts to speed corporate partnerships.